PNC-27

Description

PNC-27 oncology peptide is a laboratory grade p53-derived research peptide with minimal sequences of fifty-eight amino-acids and maximum sequences of twenty-seven amino acids developed from a aggressive specific cell death-pathway and an active cancer cell membrane dynamic. This peptide is geared toward in vitro research compounds that allow investigators to study membranolytic mechanics, pore formation, and peptide-mediated apoptosis in model cell cultures. All batches are provided as high purity peptides, COA verified peptides and third party tested peptides for reproducible results and reliable experiments. You can also order high purity HPLC tested compounds and certificate of analysis peptide documentation for accurate synthesis USA in strain free laboratory workflows. PNC-27 is provided to the researchers who purchase peptides on-line as a product representing all requirements of 99% pure peptide supplier of pharmaceutical grade research chemicals, peptides bioregulators and lyophilised peptide reconstitution options. This material is for laboratory research use only, not for human consumption, therapeutic or diagnostic purposes.